• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产儿的肠道微生物群与神经发育:机制洞察及临床转化前景

Gut Microbiota and Neurodevelopment in Preterm Infants: Mechanistic Insights and Prospects for Clinical Translation.

作者信息

Dai Kun, Ding Lingli, Yang Xiaomeng, Wang Suqing, Rong Zhihui

机构信息

School of Nursing, Wuhan University, Wuhan 430071, China.

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Microorganisms. 2025 Sep 22;13(9):2213. doi: 10.3390/microorganisms13092213.

DOI:10.3390/microorganisms13092213
PMID:41011544
Abstract

Preterm birth remains a significant global health challenge and is strongly associated with heightened risks of long-term neurodevelopmental impairments, including cognitive delays, behavioural disorders, and emotional dysregulation. In recent years, accumulating evidence has underscored the critical role of the gut microbiota in early brain development through the gut-brain axis. In preterm infants, microbial colonisation is frequently delayed or disrupted due to caesarean delivery, perinatal antibiotic exposure, formula feeding, and prolonged stays in neonatal intensive care units (NICUs), all of which contribute to gut dysbiosis during critical periods of neurodevelopment. This review synthesises current knowledge on the sources, temporal patterns, and determinants of gut microbiota colonisation in preterm infants. This review focuses on the gut bacteriome and uses faecal-sample bacteriome sequencing as its primary method of characterisation. We detail five mechanistic pathways that link microbial disturbances to adverse neurodevelopmental outcomes: immune activation and white matter injury, short-chain fatty acids (SCFAs)-mediated neuroprotection, tryptophan-serotonin metabolic signalling, hypothalamic-pituitary-adrenal (HPA) axis modulation, and the integrity of intestinal and blood-brain barriers (BBB). We also critically examine emerging microbiota-targeted interventions-including probiotics, prebiotics, human milk oligosaccharides (HMOs), antibiotic stewardship strategies, skin-to-skin contact (SSC), and faecal microbiota transplantation (FMT)-focusing on their mechanisms of action, translational potential, and associated ethical concerns. Finally, we identify key research gaps, including the scarcity of longitudinal studies, limited functional modelling, and the absence of standardised protocols across clinical settings. A comprehensive understanding of microbial-neurodevelopmental interactions may provide a foundation for the development of targeted, timing-sensitive, and ethically sound interventions aimed at improving neurodevelopmental outcomes in this vulnerable population.

摘要

早产仍然是一项重大的全球健康挑战,并且与长期神经发育障碍的高风险密切相关,这些障碍包括认知延迟、行为障碍和情绪调节障碍。近年来,越来越多的证据强调了肠道微生物群通过肠-脑轴在早期大脑发育中的关键作用。在早产儿中,由于剖宫产、围产期抗生素暴露、配方奶喂养以及在新生儿重症监护病房(NICU)的长时间停留,微生物定植常常延迟或中断,所有这些因素都导致了神经发育关键时期的肠道菌群失调。本综述综合了关于早产儿肠道微生物群定植的来源、时间模式和决定因素的现有知识。本综述聚焦于肠道细菌群落,并将粪便样本细菌群落测序作为其主要的表征方法。我们详细阐述了将微生物紊乱与不良神经发育结局联系起来的五条机制途径:免疫激活和白质损伤、短链脂肪酸(SCFA)介导的神经保护、色氨酸-血清素代谢信号传导、下丘脑-垂体-肾上腺(HPA)轴调节以及肠道和血脑屏障(BBB)的完整性。我们还批判性地审视了新兴的针对微生物群的干预措施,包括益生菌、益生元、人乳寡糖(HMO)、抗生素管理策略、皮肤接触(SSC)和粪便微生物群移植(FMT),重点关注它们的作用机制、转化潜力以及相关的伦理问题。最后,我们确定了关键的研究空白,包括纵向研究的稀缺、有限的功能建模以及临床环境中缺乏标准化方案。对微生物与神经发育相互作用的全面理解可能为开发旨在改善这一脆弱人群神经发育结局的有针对性、时机敏感且符合伦理的干预措施提供基础。

相似文献

1
Gut Microbiota and Neurodevelopment in Preterm Infants: Mechanistic Insights and Prospects for Clinical Translation.早产儿的肠道微生物群与神经发育:机制洞察及临床转化前景
Microorganisms. 2025 Sep 22;13(9):2213. doi: 10.3390/microorganisms13092213.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.基于肠道微生物群的干预措施用于管理19岁及以下儿童和青少年的肥胖问题。
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
4
Microbiota Gut-Brain Axis and Autism Spectrum Disorder: Mechanisms and Therapeutic Perspectives.微生物群-肠-脑轴与自闭症谱系障碍:机制与治疗前景
Nutrients. 2025 Sep 17;17(18):2984. doi: 10.3390/nu17182984.
5
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis.目前关于肠-肝轴以及与肠道微生物群失调相关的非酒精性脂肪性肝病/非酒精性脂肪性肝炎分子基础的研究结果。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04069-z.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants.预防早产和/或低出生体重儿出生时体温过低的干预措施。
Cochrane Database Syst Rev. 2018 Feb 12;2(2):CD004210. doi: 10.1002/14651858.CD004210.pub5.
10
Aspects of Genetic Diversity, Host Specificity and Public Health Significance of Single-Celled Intestinal Parasites Commonly Observed in Humans and Mostly Referred to as 'Non-Pathogenic'.人类常见且大多被称为“非致病性”的单细胞肠道寄生虫的遗传多样性、宿主特异性及公共卫生意义
APMIS. 2025 Sep;133(9):e70036. doi: 10.1111/apm.70036.

本文引用的文献

1
The changing prevalence of ADHD? A systematic review.注意缺陷多动障碍患病率的变化?一项系统综述。
J Affect Disord. 2025 Nov 1;388:119427. doi: 10.1016/j.jad.2025.119427. Epub 2025 May 18.
2
Faecal microbiota transplantation for recurrent Clostridiodes difficile infection & its global regulatory landscape.粪菌移植治疗复发性艰难梭菌感染及其全球监管格局。
Indian J Med Res. 2025 Feb;161(2):113-119. doi: 10.25259/IJMR_818_2024.
3
Gut Microbiota Alteration in Healthy Preterm Infants: An Observational Study from Tertiary Care Center in India.
印度三级医疗中心对健康早产儿肠道微生物群变化的一项观察性研究。
Microorganisms. 2025 Mar 3;13(3):577. doi: 10.3390/microorganisms13030577.
4
Composition of the fecal, vaginal and colostrum microbiotas of dams at parturition and their relationship with neonatal outcomes in dogs.分娩时母犬粪便、阴道和初乳微生物群的组成及其与犬新生儿结局的关系。
Anim Microbiome. 2025 Mar 6;7(1):23. doi: 10.1186/s42523-025-00384-1.
5
Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit/hyperactivity disorder.精神兴奋剂对注意缺陷多动障碍儿童微生物群和短链脂肪酸改变的影响。
Sci Rep. 2025 Jan 24;15(1):3034. doi: 10.1038/s41598-025-87546-y.
6
Bacterial extracellular vesicles at the interface of gut microbiota and immunity.肠道微生物群和免疫的细菌细胞外囊泡。
Gut Microbes. 2024 Jan-Dec;16(1):2396494. doi: 10.1080/19490976.2024.2396494. Epub 2024 Sep 28.
7
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics.端到端供体筛选和生产控制:基于质量的互补策略,最大限度地降低供体衍生微生物组治疗产品的患者风险。
Gut Microbes. 2024 Jan-Dec;16(1):2402550. doi: 10.1080/19490976.2024.2402550. Epub 2024 Sep 18.
8
The gut-microbiome in adult Attention-deficit/hyperactivity disorder - A Meta-analysis.成人注意缺陷多动障碍的肠道微生物组 - 一项荟萃分析。
Eur Neuropsychopharmacol. 2024 Nov;88:21-29. doi: 10.1016/j.euroneuro.2024.07.004. Epub 2024 Aug 8.
9
Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI.重新评估 FDA 对早产儿使用益生菌的警告:ESPGHAN 和 EFCNI 的社会声明。
J Pediatr Gastroenterol Nutr. 2024 Jun;78(6):1403-1408. doi: 10.1002/jpn3.12204. Epub 2024 Apr 4.
10
Short-chain fatty acids: linking diet, the microbiome and immunity.短链脂肪酸:连接饮食、微生物组和免疫。
Nat Rev Immunol. 2024 Aug;24(8):577-595. doi: 10.1038/s41577-024-01014-8. Epub 2024 Apr 2.